Improving cancer detection using advanced light technology and machine learning
Official title: Metasurface enhanced and machine learning aided spectrochemical liquid biopsy
Funded at University of Wisconsin-Madison · NIH-11030790 · Data updated 2026-11-12
This study is working on a new, easy way to find cancer markers in body fluids without needing invasive procedures, using advanced technology to make early detection and monitoring of cancer more accurate and convenient for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | March 1, 2023 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $148,840 |
| NIH project number | 5R21EB034411-03 |
| Project ID | NIH-11030790 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for cancer or those undergoing monitoring for cancer recurrence.
✕Less likely to help
Patients with cancers that are not detectable through liquid biopsy methods may not benefit from this research.
What this research studies
This research focuses on developing a new method for detecting cancer-related biomarkers in body fluids through a non-invasive liquid biopsy approach. By utilizing advanced spectrochemical techniques, such as Raman and infrared spectroscopy, combined with machine learning, the project aims to enhance the sensitivity and accuracy of cancer detection. The innovative use of electromagnetic metasurfaces is expected to improve the performance of these diagnostic tools, making them more effective for early cancer detection and patient monitoring. Ultimately, the goal is to create a portable and user-friendly platform that can be used in clinical settings.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate cancer detection, potentially improving survival rates for patients.
How similar studies have gone: Other research has shown promise in using advanced spectrochemical techniques for cancer detection, indicating that this approach could be a significant advancement in the field.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Yesilkoy, Filiz — University of Wisconsin-Madison
- Study coordinator: Yesilkoy, Filiz
Related research
Other NIH-funded projects on the same topics.
-
Towards a blood-based test using nanophotonic exosomes to screen and diagnose liver cancer
A new blood test using tiny particles shed by liver cancer cells aims to screen for hepatocellular carcinoma earlier and more accurately.
-
Liquid biopsy test to screen for lymphoma in people with HIV
A new blood test called High Density Methyl-Seq is being checked to see if it can detect lymphoma early in people living with HIV.
-
Liquid biopsy and oxygen therapy to guide glioblastoma treatment
A patient-focused study exploring a blood-based test and a safe oxygen therapy to help doctors tell true tumor growth from treatment effects in adults with glioblastoma treated with chemoradiation.
-
Liquid biopsy to monitor LMS treatment and resistance
A patient-centered look at using blood tests to see how well LMS treatment is working and when resistance to therapy appears.
-
Imagnostix: a simple blood-based test to flag Alzheimer’s risk
A new blood-based test called Imagnostix aims to help identify people who may be developing Alzheimer’s disease earlier and more cheaply than current methods.
-
Multi-omic liquid biopsy to guide immunotherapy in colorectal and anal cancers
A patient-facing overview of a study testing blood-based biomarkers (ctDNA and extracellular RNA) to better tailor immunotherapy for colorectal and anal cancer patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.